Procedural characteristics of pulmonary vein isolation with high
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12872-022-02459-2/MediaObjects/12872_2022_2459_Fig1_HTML.png)
The purpose of this study was to investigate the safety and efficacy of high-power short-duration (HP-SD) ablation compared to conventional ablation in patients with atrial fibrillation (AF). We enrolled consecutive 158 drug-refractory symptomatic AF patients (119 males, mean age 63 ± 10 years) who had undergone first radiofrequency pulmonary vein isolation (PVI). PVI was performed using the conventional setting (20–35 W) in 73 patients (Conventional group) and using the HP-SD setting (45–50 W) in 85 patients (HP-SD group). The rate of first pass isolation, remaining gaps after circumferential ablation, dormant conduction, and the radiofrequency application time in each pulmonary vein (PV) were compared between the groups. The first pass isolation ratio was significantly higher in the HP-SD group than in the Conventional group (81% vs. 65%, P = 0.027) in the right PV, but did not differ in the left PV. The remaining gaps were fewer in the right superior PV (4% vs. 21%, P = 0.001) and left inferior PV (1% vs. 8%, P = 0.032) areas, and the radiofrequency application time in each PV was shorter (right PV, 12.0 ± 8.9 min vs. 34.0 ± 31.7 min, P < 0.001; left PV, 10.6 ± 3.6 min vs. 25.7 ± 22.3 min, P < 0.001) in the HP-SD group than in the Conventional group. The use of the HP-SD setting might contribute to improve the first pass isolation rate and to shorten the radiofrequency application time in each PV.
![](https://www.researchgate.net/publication/309724549/figure/fig5/AS:661807005962241@1534798494794/Pulmonary-vein-isolation-using-a-standard-radiofrequency-catheter-A-Catheters-that.png)
Pulmonary vein isolation using a standard radiofrequency catheter
SVT Ablation
![](https://www.researchgate.net/publication/376015277/figure/fig1/AS:11431281210733133@1702101123825/Changes-in-activities-of-A-factor-II-B-factor-VII-and-C-factor-X-and-D_Q320.jpg)
Tomohiro Ohigashi's research works University of Tsukuba, Tsukuba and other places
![](https://i1.rgstatic.net/ii/profile.image/1122766954729472-1644699910134_Q64/Carolina-Saleiro.jpg)
Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-020-00451-x/MediaObjects/41569_2020_451_Fig1_HTML.png)
Catheter ablation for atrial fibrillation: current indications and
![](https://abccardiol.org/wp-content/uploads/2021/07/0066-782X-abc-117-01-0100-gf01-en.jpg)
Reconnection Sites in Redo Ablation after Cryoballoon Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation - ABC Cardiol
![](https://www.researchgate.net/publication/358088417/figure/fig3/AS:1115972794613791@1643080056677/Distribution-of-the-remaining-gaps-after-circumferential-ablation-in-each-PV-The_Q320.jpg)
Patient flow diagram. After the exclusion criteria, the study patients
![](https://www.melbourneheartrhythm.com.au/images/procedures/af-ablation/AF-vs-SR-image.jpg)
Atrial Fibrillation Ablation - Melbourne Heart Rhythm
![](https://www.stopafib.org/content/uploads/2021/10/SAF-60-Catheter-Ablation-AdobeStock_325760392-scaled.jpeg)
Catheter Ablation for Atrial Fibrillation Overview
![](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs56000%2F56549/img/fig1.jpg)
Pulmonary vein isolation in the treatment of atrial fibrillation